Guidelines, supported by several medical societies, offer direction for post-operative and “definitive” settings.
This week, the American Society for Radiation Oncology (ASTRO) released its first clinical guidelines for using radiation therapy to treat patients who have non-metastatic cervical cancer.
The guidelines, published in Practical Radiation Oncology, discuss best practices for using external-beam radiation therapy (EBRT) and brachytherapy in both post-operative and “definitive” settings. This guidance also touches on using chemotherapy and surgery in combination with radiation treatments, as well as intensity-modulated radiation therapy (IMRT).
"Cervical cancer treatment has advanced dramatically over the last 20 years. Increased use of intensity-modulated radiation therapy (IMRT) and image-guided brachytherapy, in particular, have resulted in better patient outcomes and fewer treatment complications," said Akila N. Viswanathan, M.D., MPH, guideline task force chair and professor and interim director of radiation oncology and molecular radiation sciences at the Johns Hopkins Sidney Kimmel Cancer Center in Baltimore. "Our intention in developing this guideline is to encourage physicians to make these approaches part of their daily practice."
A multi-disciplinary panel reviewed scientific articles published from January 1993 to October 2018 to draft the guidelines. And, several societies, including the Canadian Association of Radiation Oncology, the European Society for Radiotherapy and Oncology, and the Society of Gynecologic Oncology have endorsed them.
Specific recommendations for locally advanced cancer were:
Additionally, the guidelines conditionally recommended implementing radiation or chemoradiation in definitive setting for patients with FIGO stage IA1-IB2 cancers who are unable to undergo surgery, brachytherapy for patients with positive margins, and IMRT alongside EBRT in the definitive setting.
It is important to note, Viswanathan cautioned, that these guidelines were drafted prior to the COVID-19 pandemic so they do not address the virus or any impact it might have on cervical cancer treatment. However, the guidelines task force did caution against postponing cervical cancer treatment during the outbreak.
“Cervical cancer is one of those cancers where you just can’t wait,” she said. "You need to treat it right away in order to have the greatest chance of cure."
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.